Drugs & Therapy Perspectives

, Volume 34, Issue 8, pp 367–367 | Cite as

First reports of adverse drug reactions

Drug Reactions and Interactions
Table 1 contains an overview of first published case reports of adverse drug reactions identified in the international literature in recent weeks by Reactions Weekly, the Adis drug safety newsletter. Reactions Weekly provides summaries of adverse drug reaction news sourced from journals, scientific meetings, media releases, regulatory agency websites, and bulletins from the National Centers that participate in the WHO International Drug Monitoring Programme.
Table 1

First published reports of adverse drug reactions recently identified by Reactions Weekly

Drug and adverse reaction


Abacavir/dolutegravir/lamivudine: photoallergic dermatitis (serious)

Chuang Z-M, Chen T-C. Photoallergic dermatitis associated with fixed-dose combination of antiretroviral agent (abacavir-lamivudine-dolutegravir) [letter]. AIDS. 2018;32(10):1385-8.

Apixaban: acute generalised exanthematous pustulosis (serious)

Aweid B, Ahmed M, Punjabi S, et al. Acute generalised exanthematous pustulosis (agep) secondary to apixaban [abstract no. AS31-031]. Eur Stroke J. 2018;3(Suppl 1):562.

Elotuzumab: interstitial lung disease (serious)

Tanaka T, Saito Y, Kokuho N, et al. Elotuzumab-induced interstitial lung disease: the first case report. Jpn J Clin Oncol. 2018;48(5):491-4.

Golimumab: thrombotic thrombocytopenic purpura (serious)

Cepeda J, Liedke C, Patnaik A, et al. Development of thrombotic thrombocytopenic purpura in association with the monoclonal antibody, golimumab, used to treat rheumatoid arthritis, in a case with literature review. J Clin Rheumatol. 2018;24(4):229-31.

Meningococcal polysaccharide conjugate vacccine: inflammatory response and cryopyrin-associated periodic syndrome (serious)

Walker UA, Volksbeck SL, Kuemmerle-Deschner J. Flare of a cryopyrin-associated periodic syndrome following vaccination with neisseria meningitidis polysaccharides [letter]. J Rheumatol. 2018;45(6):878-9.

Perampanel: delirium (serious)

Takeshima M, Ishikawa H, Ono T, et al. A case of perampanel-induced delirium in a patient with symptomatic epilepsy. Seizure. 2018;58:154-5.

Silver nitrate: iatrogenic external auditory canal stenosis (serious)

Mikals SJ, Huang Z, Reilly BK, et al. Iatrogenic external auditory canal stenosis induced by silver nitrate. Ear Nose Throat J. 2018;97(4):E39.

Thiamazole: frosted branch angiitis associated with systemic vasculitis (serious)

Koike KJ, Blice JP, Kylstra JA, et al. Frosted branch angiitis in methimazole-induced antineutrophil cytoplasmic antibody-positive vasculitis. Retin Cases Brief Rep. 2018;12(2):136-9.

Ustekinumab: chronic inflammatory demyelinating polyneuropathy (serious)

Osman G, Shah K, Khan MS, et al. Ustekinumab related CIDP in a patient with psoriatic arthritis [abstract no. P2.451]. Neurology. 2018;90(15 Suppl).

An event is serious (US FDA MedWatch definition) when the patient outcome is death, life threatening, hospitalization, disability, congenital anomaly or requires intervention to prevent permanent impairment or damage

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations